INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Evolus, Inc. - EOLS

Pomerantz LLP is investigating Evolus, Inc. for potential securities fraud following an FDA warning letter on October 2, 2026, that flagged misleading Instagram promotion of its wrinkle treatment Jeuveau. The FDA objected to false claims about the product's efficacy and safety information minimization. Evolus's stock fell 7.15% to $7.14 per share on the news.